{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T16:34:59Z","timestamp":1777739699608,"version":"3.51.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02571-y","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T02:41:07Z","timestamp":1745808067000},"page":"1635-1647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pediatric and adolescent von Hippel-Lindau disease: tumor profiles, genotype-phenotype correlation and comparison with adults"],"prefix":"10.1007","volume":"48","author":[{"given":"Anima","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketki","family":"Ambulkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjiri","family":"Karlekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5199-6299","authenticated-orcid":false,"given":"Saba Samad","family":"Memon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virendra","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitish","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijaya","family":"Sarathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurag","family":"Lila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer","family":"Rege","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemangini","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Barnabas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalini","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tushar","family":"Bandgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"2571_CR1","doi-asserted-by":"publisher","first-page":"104538","DOI":"10.1016\/j.ejmg.2022.104538","volume":"65","author":"M Louise","year":"2022","unstructured":"Louise M, Binderup M, Smerdel M, Borgwadt L et al (2022) Von Hippel-Lindau disease: updated guideline for diagnosis and surveillance. Eur J Med Genet 65:104538. https:\/\/doi.org\/10.1016\/j.ejmg.2022.104538","journal-title":"Eur J Med Genet"},{"key":"2571_CR2","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.4161\/cc.8.22.9907","volume":"8","author":"CR Thoma","year":"2009","unstructured":"Thoma CR, Toso A, Meraldi P, Krek W (2009) Double-trouble in mitosis caused by von Hippel-Lindau tumor-suppressor protein inactivation. Cell Cycle Georget Tex 8:3619\u20133620. https:\/\/doi.org\/10.4161\/cc.8.22.9907","journal-title":"Cell Cycle Georget Tex"},{"key":"2571_CR3","doi-asserted-by":"publisher","first-page":"41038","DOI":"10.1038\/srep41038","volume":"7","author":"J Wang","year":"2017","unstructured":"Wang J, Lu Z, Xu Z et al (2017) Reduction of hepatic fibrosis by overexpression of von Hippel-Lindau protein in experimental models of chronic liver disease. Sci Rep 7:41038. https:\/\/doi.org\/10.1038\/srep41038","journal-title":"Sci Rep"},{"key":"2571_CR4","first-page":"B5461","volume":"65","author":"MLM Binderup","year":"2018","unstructured":"Binderup MLM (2018) Von Hippel-Lindau disease: diagnosis and factors influencing disease outcome. Dan Med J 65:B5461","journal-title":"Dan Med J"},{"key":"2571_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/ejhg.2016.173","volume":"25","author":"MLM Binderup","year":"2017","unstructured":"Binderup MLM, Galanakis M, Budtz-J\u00f8rgensen E et al (2017) Prevalence, birth incidence, and penetrance of von Hippel-Lindau disease (vHL) in Denmark. Eur J Hum Genet EJHG 25:301\u2013307. https:\/\/doi.org\/10.1038\/ejhg.2016.173","journal-title":"Eur J Hum Genet EJHG"},{"key":"2571_CR6","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s41416-022-01724-7","volume":"126","author":"ER Maher","year":"2022","unstructured":"Maher ER, Adlard J, Barwell J et al (2022) Evaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a National health service. Br J Cancer 126:1339\u20131345. https:\/\/doi.org\/10.1038\/s41416-022-01724-7","journal-title":"Br J Cancer"},{"key":"2571_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/humu.21219","volume":"31","author":"M Nordstrom-O\u2019Brien","year":"2010","unstructured":"Nordstrom-O\u2019Brien M, van der Luijt RB, van Rooijen E et al (2010) Genetic analysis of von Hippel-Lindau disease. Hum Mutat 31:521\u2013537. https:\/\/doi.org\/10.1002\/humu.21219","journal-title":"Hum Mutat"},{"key":"2571_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/humu.20385","volume":"28","author":"KR Ong","year":"2007","unstructured":"Ong KR, Woodward ER, Killick P et al (2007) Genotype-phenotype correlations in von Hippel-Lindau disease. Hum Mutat 28:143\u2013149. https:\/\/doi.org\/10.1002\/humu.20385","journal-title":"Hum Mutat"},{"key":"2571_CR9","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1530\/ERC-18-0100","volume":"25","author":"T Krauss","year":"2018","unstructured":"Krauss T, Ferrara AM, Links TP et al (2018) Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors. Endocr Relat Cancer 25:783\u2013793. https:\/\/doi.org\/10.1530\/ERC-18-0100","journal-title":"Endocr Relat Cancer"},{"key":"2571_CR10","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1002\/ajmg.a.38324","volume":"173","author":"K Launbjerg","year":"2017","unstructured":"Launbjerg K, Bache I, Galanakis M et al (2017) Von Hippel-Lindau development in children and adolescents. Am J Med Genet A 173:2381\u20132394. https:\/\/doi.org\/10.1002\/ajmg.a.38324","journal-title":"Am J Med Genet A"},{"key":"2571_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.surg.2016.05.059","volume":"161","author":"B Babic","year":"2017","unstructured":"Babic B, Patel D, Aufforth R et al (2017) Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors. Surgery 161:220\u2013227. https:\/\/doi.org\/10.1016\/j.surg.2016.05.059","journal-title":"Surgery"},{"key":"2571_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1530\/ERC-13-0415","volume":"21","author":"B Bausch","year":"2014","unstructured":"Bausch B, Wellner U, Bausch D et al (2014) Long-term prognosis of patients with pediatric pheochromocytoma. Endocr Relat Cancer 21:17\u201325. https:\/\/doi.org\/10.1530\/ERC-13-0415","journal-title":"Endocr Relat Cancer"},{"key":"2571_CR13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s11060-024-04676-5","volume":"168","author":"AL Knoblauch","year":"2024","unstructured":"Knoblauch AL, Bla\u00df B-I, Steiert C et al (2024) Screening and surveillance recommendations for central nervous system hemangioblastomas in pediatric patients with von Hippel-Lindau disease. J Neurooncol 168:537\u2013545. https:\/\/doi.org\/10.1007\/s11060-024-04676-5","journal-title":"J Neurooncol"},{"key":"2571_CR14","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1002\/cncr.34896","volume":"129","author":"AB Daniels","year":"2023","unstructured":"Daniels AB, Tirosh A, Huntoon K et al (2023) Guidelines for surveillance of patients with von Hippel-Lindau disease: consensus statement of the international VHL surveillance guidelines consortium and VHL alliance. Cancer 129:2927\u20132940. https:\/\/doi.org\/10.1002\/cncr.34896","journal-title":"Cancer"},{"key":"2571_CR15","doi-asserted-by":"publisher","unstructured":"R van L SL, D P, et al (2022) Management recommendations for pancreatic manifestations of von Hippel-Lindau disease. Cancer 128. https:\/\/doi.org\/10.1002\/cncr.33978","DOI":"10.1002\/cncr.33978"},{"key":"2571_CR16","doi-asserted-by":"publisher","unstructured":"Casey RT, Hendriks E, Deal C et al (2024) International consensus statement on the diagnosis and management of Phaeochromocytoma and paraganglioma in children and adolescents. Nat Rev Endocrinol 1\u201320. https:\/\/doi.org\/10.1038\/s41574-024-01024-5","DOI":"10.1038\/s41574-024-01024-5"},{"key":"2571_CR17","unstructured":"Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents| Pediatrics| American Academy of Pediatrics. https:\/\/publications.aap.org\/pediatrics\/article\/140\/3\/e20171904\/38358\/Clinical-Practice-Guideline-for-Screening-and?autologincheck=redirected. Accessed 13 Oct 2024"},{"key":"2571_CR18","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1148\/rg.2018170156","volume":"38","author":"D Ganeshan","year":"2018","unstructured":"Ganeshan D, Menias CO, Pickhardt PJ et al (2018) Tumors in von Hippel-Lindau syndrome: from head to Toe-Comprehensive State-of-the-Art review. Radiogr Rev Publ Radiol Soc N Am Inc 38:849\u2013866. https:\/\/doi.org\/10.1148\/rg.2018170156","journal-title":"Radiogr Rev Publ Radiol Soc N Am Inc"},{"key":"2571_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz LH, Liti\u00e8re S, de Vries E et al (2016) RECIST 1.1\u2013 Update and clarification: from the RECIST committee. Eur J Cancer Oxf Engl 1990 62:132\u2013137. https:\/\/doi.org\/10.1016\/j.ejca.2016.03.081","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"2571_CR20","first-page":"206","volume":"22","author":"BC Chu","year":"2001","unstructured":"Chu BC, Terae S, Hida K et al (2001) MR findings in spinal hemangioblastoma: correlation with symptoms and with angiographic and surgical findings. AJNR Am J Neuroradiol 22:206\u2013217","journal-title":"AJNR Am J Neuroradiol"},{"key":"2571_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41408-018-0054-y","volume":"8","author":"T Barbui","year":"2018","unstructured":"Barbui T, Thiele J, Gisslinger H et al (2018) The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. Blood Cancer J 8:15. https:\/\/doi.org\/10.1038\/s41408-018-0054-y","journal-title":"Blood Cancer J"},{"key":"2571_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10689-017-0058-y","volume":"17","author":"N Lomte","year":"2018","unstructured":"Lomte N, Kumar S, Sarathi V et al (2018) Genotype phenotype correlation in Asian Indian von Hippel-Lindau (VHL) syndrome patients with pheochromocytoma\/paraganglioma. Fam Cancer 17:441\u2013449. https:\/\/doi.org\/10.1007\/s10689-017-0058-y","journal-title":"Fam Cancer"},{"key":"2571_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1530\/EJE-16-0126","volume":"175","author":"R Pandit","year":"2016","unstructured":"Pandit R, Khadilkar K, Sarathi V et al (2016) Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma. Eur J Endocrinol 175:311\u2013323. https:\/\/doi.org\/10.1530\/EJE-16-0126","journal-title":"Eur J Endocrinol"},{"key":"2571_CR24","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/jhg.2014.61","volume":"59","author":"S Hwang","year":"2014","unstructured":"Hwang S, Ku CR, Lee JI et al (2014) Germline mutation of Glu70Lys is highly frequent in Korean patients with von Hippel\u2013Lindau (VHL) disease. J Hum Genet 59:488\u2013493. https:\/\/doi.org\/10.1038\/jhg.2014.61","journal-title":"J Hum Genet"},{"key":"2571_CR25","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1210\/js.2019-00225","volume":"3","author":"GFC Fagundes","year":"2019","unstructured":"Fagundes GFC, Petenuci J, Lourenco DM et al (2019) New insights into pheochromocytoma surveillance of young patients with VHL missense mutations. J Endocr Soc 3:1682\u20131692. https:\/\/doi.org\/10.1210\/js.2019-00225","journal-title":"J Endocr Soc"},{"key":"2571_CR26","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1007\/s00345-020-03441-3","volume":"39","author":"J Chahoud","year":"2021","unstructured":"Chahoud J, McGettigan M, Parikh N et al (2021) Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease. World J Urol 39:2409\u20132415. https:\/\/doi.org\/10.1007\/s00345-020-03441-3","journal-title":"World J Urol"},{"key":"2571_CR27","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.1055\/s-0041-1725033","volume":"83","author":"GU Mehta","year":"2021","unstructured":"Mehta GU, Kim HJ, Gidley PW et al (2021) Endolymphatic sac tumor screening and diagnosis in von Hippel-Lindau disease: A consensus statement. J Neurol Surg Part B Skull Base 83:e225\u2013e231. https:\/\/doi.org\/10.1055\/s-0041-1725033","journal-title":"J Neurol Surg Part B Skull Base"},{"key":"2571_CR28","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1210\/jc.2015-3045","volume":"100","author":"RD Aufforth","year":"2015","unstructured":"Aufforth RD, Ramakant P, Sadowski SM et al (2015) Pheochromocytoma screening initiation and frequency in von Hippel-Lindau syndrome. J Clin Endocrinol Metab 100:4498\u20134504. https:\/\/doi.org\/10.1210\/jc.2015-3045","journal-title":"J Clin Endocrinol Metab"},{"key":"2571_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/cen.14467","volume":"95","author":"J Petenuci","year":"2021","unstructured":"Petenuci J, Guimaraes AG, Fagundes GFC et al (2021) Genetic and clinical aspects of paediatric pheochromocytomas and paragangliomas. Clin Endocrinol (Oxf) 95:117\u2013124. https:\/\/doi.org\/10.1111\/cen.14467","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2571_CR30","doi-asserted-by":"publisher","first-page":"L1","DOI":"10.1530\/ERC-12-0339","volume":"20","author":"A Casc\u00f3n","year":"2013","unstructured":"Casc\u00f3n A, Inglada-P\u00e9rez L, Comino-M\u00e9ndez I et al (2013) Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients. Endocr Relat Cancer 20:L1\u20136. https:\/\/doi.org\/10.1530\/ERC-12-0339","journal-title":"Endocr Relat Cancer"},{"key":"2571_CR31","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1210\/jc.2009-0354","volume":"94","author":"CC Boedeker","year":"2009","unstructured":"Boedeker CC, Erlic Z, Richard S et al (2009) Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 94:1938\u20131944. https:\/\/doi.org\/10.1210\/jc.2009-0354","journal-title":"J Clin Endocrinol Metab"},{"key":"2571_CR32","doi-asserted-by":"publisher","unstructured":"Volkin D, Yerram N, Ahmed F et al (2012) Partial adrenalectomy minimizes the need for Long-Term hormone replacement in pediatric patients with pheochromocytoma and von Hippel-Lindau syndrome. J Pediatr Surg 47. https:\/\/doi.org\/10.1016\/j.jpedsurg.2012.07.003","DOI":"10.1016\/j.jpedsurg.2012.07.003"},{"key":"2571_CR33","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jpedsurg.2021.04.007","volume":"57","author":"NS Rubalcava","year":"2022","unstructured":"Rubalcava NS, Overman RE, Kartal TT et al (2022) Laparoscopic adrenal-sparing approach for children with bilateral pheochromocytoma in von Hippel-Lindau disease. J Pediatr Surg 57:414\u2013417. https:\/\/doi.org\/10.1016\/j.jpedsurg.2021.04.007","journal-title":"J Pediatr Surg"},{"key":"2571_CR34","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3171\/2014.1.JNS131431","volume":"120","author":"RR Lonser","year":"2014","unstructured":"Lonser RR, Butman JA, Huntoon K et al (2014) Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease. J Neurosurg 120:1055\u20131062. https:\/\/doi.org\/10.3171\/2014.1.JNS131431","journal-title":"J Neurosurg"},{"key":"2571_CR35","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3171\/2015.4.JNS1533","volume":"124","author":"K Huntoon","year":"2016","unstructured":"Huntoon K, Wu T, Elder JB et al (2016) Biologic and clinical impact of hemangioblastoma-associated peritumoral cysts in von Hippel-Lindau disease. J Neurosurg 124:971\u2013976. https:\/\/doi.org\/10.3171\/2015.4.JNS1533","journal-title":"J Neurosurg"},{"key":"2571_CR36","doi-asserted-by":"publisher","first-page":"40822","DOI":"10.1038\/srep40822","volume":"7","author":"S Sizdahkhani","year":"2017","unstructured":"Sizdahkhani S, Feldman MJ, Piazza MG et al (2017) Somatostatin receptor expression on von Hippel-Lindau-associated hemangioblastomas offers novel therapeutic target. Sci Rep 7:40822. https:\/\/doi.org\/10.1038\/srep40822","journal-title":"Sci Rep"},{"key":"2571_CR37","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3389\/fgene.2019.00867","volume":"10","author":"B Hong","year":"2019","unstructured":"Hong B, Ma K, Zhou J et al (2019) Frequent mutations of VHL gene and the clinical phenotypes in the largest Chinese cohort with von Hippel-Lindau disease. Front Genet 10:867. https:\/\/doi.org\/10.3389\/fgene.2019.00867","journal-title":"Front Genet"},{"key":"2571_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-3-319-95046-4_42","volume":"1085","author":"SH Tsang","year":"2018","unstructured":"Tsang SH, Sharma T (2018) Von Hippel-Lindau disease. Adv Exp Med Biol 1085:201\u2013203. https:\/\/doi.org\/10.1007\/978-3-319-95046-4_42","journal-title":"Adv Exp Med Biol"},{"key":"2571_CR39","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.jpedsurg.2007.02.029","volume":"42","author":"JM Langrehr","year":"2007","unstructured":"Langrehr JM, Bahra M, Kristiansen G et al (2007) Neuroendocrine tumor of the pancreas and bilateral adrenal pheochromocytomas. A rare manifestation of von Hippel\u2013Lindau disease in childhood. J Pediatr Surg 42:1291\u20131294. https:\/\/doi.org\/10.1016\/j.jpedsurg.2007.02.029","journal-title":"J Pediatr Surg"},{"key":"2571_CR40","doi-asserted-by":"publisher","first-page":"L43","DOI":"10.1530\/ERC-18-0123","volume":"25","author":"SM O\u2019Toole","year":"2018","unstructured":"O\u2019Toole SM, Sahdev A, Bhattacharya S et al (2018) Paediatric pancreatic neuroendocrine tumours in von Hippel-Lindau disease. Endocr Relat Cancer 25:L43\u2013L47. https:\/\/doi.org\/10.1530\/ERC-18-0123","journal-title":"Endocr Relat Cancer"},{"key":"2571_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4274\/jcrpe.5078","volume":"10","author":"A Da\u011fdeviren \u00c7ak\u0131r","year":"2018","unstructured":"Da\u011fdeviren \u00c7ak\u0131r A, Turan H, Aykut A et al (2018) Two childhood pheochromocytoma cases due to von Hippel-Lindau disease, one associated with pancreatic neuroendocrine tumor: A very rare manifestation. J Clin Res Pediatr Endocrinol 10:179\u2013182. https:\/\/doi.org\/10.4274\/jcrpe.5078","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"2571_CR42","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae310","author":"M Muller","year":"2024","unstructured":"Muller M, Hammel P, Couvelard A et al (2024) Pancreatic neuroendocrine tumors in French VHL mutation carriers. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgae310. dgae310","journal-title":"J Clin Endocrinol Metab"},{"key":"2571_CR43","doi-asserted-by":"publisher","first-page":"744316","DOI":"10.3389\/fsurg.2021.744316","volume":"8","author":"X Shen","year":"2022","unstructured":"Shen X, Yang X (2022) Comparison of outcomes of enucleation vs. Standard surgical resection for pancreatic neoplasms: A systematic review and Meta-Analysis. Front Surg 8:744316. https:\/\/doi.org\/10.3389\/fsurg.2021.744316","journal-title":"Front Surg"},{"key":"2571_CR44","doi-asserted-by":"publisher","unstructured":"Jh F, A S, V S, et al (2021) Peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors in children. Pediatr Blood Cancer 68. https:\/\/doi.org\/10.1002\/pbc.29056","DOI":"10.1002\/pbc.29056"},{"key":"2571_CR45","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1182\/blood-2003-07-2535","volume":"103","author":"VR Gordeuk","year":"2004","unstructured":"Gordeuk VR, Sergueeva AI, Miasnikova GY et al (2004) Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood 103:3924\u20133932. https:\/\/doi.org\/10.1182\/blood-2003-07-2535","journal-title":"Blood"},{"key":"2571_CR46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrc3844","volume":"15","author":"L Gossage","year":"2015","unstructured":"Gossage L, Eisen T, Maher ER (2015) VHL, the story of a tumour suppressor gene. Nat Rev Cancer 15:55\u201364. https:\/\/doi.org\/10.1038\/nrc3844","journal-title":"Nat Rev Cancer"},{"key":"2571_CR47","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1177\/2040620712458947","volume":"3","author":"MF McMullin","year":"2012","unstructured":"McMullin MF (2012) Diagnosis and management of congenital and idiopathic erythrocytosis. Ther Adv Hematol 3:391\u2013398. https:\/\/doi.org\/10.1177\/2040620712458947","journal-title":"Ther Adv Hematol"},{"key":"2571_CR48","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1182\/blood-2018-03-838235","volume":"132","author":"M Lenglet","year":"2018","unstructured":"Lenglet M, Robriquet F, Schwarz K et al (2018) Identification of a new VHL exon and complex splicing alterations in Familial erythrocytosis or von Hippel-Lindau disease. Blood 132:469\u2013483. https:\/\/doi.org\/10.1182\/blood-2018-03-838235","journal-title":"Blood"},{"key":"2571_CR49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/00000441-198702000-00009","volume":"293","author":"C Burns","year":"1987","unstructured":"Burns C, Levine PH, Reichman H, Stock JL (1987) Adrenal hemangioblastoma in von Hippel-Lindau disease as a cause of secondary erythrocytosis. Am J Med Sci 293:119\u2013121. https:\/\/doi.org\/10.1097\/00000441-198702000-00009","journal-title":"Am J Med Sci"},{"key":"2571_CR50","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1200\/JCO.2011.38.6797","volume":"30","author":"S Capodimonti","year":"2012","unstructured":"Capodimonti S, Teofili L, Martini M et al (2012) Von Hippel-Lindau disease and erythrocytosis. J Clin Oncol 30:e137\u2013e139. https:\/\/doi.org\/10.1200\/JCO.2011.38.6797","journal-title":"J Clin Oncol"},{"key":"2571_CR51","doi-asserted-by":"publisher","first-page":"341","DOI":"10.24875\/BMHIM.20000129","volume":"78","author":"PM N\u00fa\u00f1ez-Mart\u00ednez","year":"2021","unstructured":"N\u00fa\u00f1ez-Mart\u00ednez PM, Taja-Chayeb L, Ram\u00edrez-Otero MA et al (2021) Familial erythrocytosis 2 and von Hippel-Lindau disease in the same pediatric patient. Bol Med Hosp Infant Mex 78:341\u2013345. https:\/\/doi.org\/10.24875\/BMHIM.20000129","journal-title":"Bol Med Hosp Infant Mex"},{"key":"2571_CR52","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1182\/blood.V92.9.3388","volume":"92","author":"M Krieg","year":"1998","unstructured":"Krieg M, Marti HH, Plate KH (1998) Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function. Blood 92:3388\u20133393","journal-title":"Blood"},{"key":"2571_CR53","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1136\/jmedgenet-2017-104882","volume":"55","author":"L Aronoff","year":"2018","unstructured":"Aronoff L, Malkin D, van Engelen K et al (2018) Evidence for genetic anticipation in vonHippel-Lindau syndrome. J Med Genet 55:395\u2013402. https:\/\/doi.org\/10.1136\/jmedgenet-2017-104882","journal-title":"J Med Genet"},{"key":"2571_CR54","doi-asserted-by":"publisher","first-page":"567","DOI":"10.21037\/jgo.2020.03.11","volume":"11","author":"A Tirosh","year":"2020","unstructured":"Tirosh A, Kebebew E (2020) Genetic and epigenetic alterations in pancreatic neuroendocrine tumors. J Gastrointest Oncol 11:567\u2013577. https:\/\/doi.org\/10.21037\/jgo.2020.03.11","journal-title":"J Gastrointest Oncol"},{"key":"2571_CR55","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/gim.2015.44","volume":"18","author":"MLM Binderup","year":"2016","unstructured":"Binderup MLM, Budtz-J\u00f8rgensen E, Bisgaard ML (2016) Risk of new tumors in von Hippel\u2013Lindau patients depends on age and genotype. Genet Med 18:89\u201397. https:\/\/doi.org\/10.1038\/gim.2015.44","journal-title":"Genet Med"},{"key":"2571_CR56","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1297\/cpe.27.87","volume":"27","author":"J Igaki","year":"2018","unstructured":"Igaki J, Nishi A, Sato T, Hasegawa T (2018) A pediatric case of pheochromocytoma without apparent hypertension associated with von Hippel-Lindau disease. Clin Pediatr Endocrinol 27:87\u201393. https:\/\/doi.org\/10.1297\/cpe.27.87","journal-title":"Clin Pediatr Endocrinol"},{"key":"2571_CR57","doi-asserted-by":"publisher","unstructured":"C PS U, S U, et al (2010) Pheochromocytoma in a 2.75-year-old-girl with a germline von Hippel-Lindau mutation Q164R. Am J Med Genet A 152A. https:\/\/doi.org\/10.1002\/ajmg.a.33407","DOI":"10.1002\/ajmg.a.33407"},{"key":"2571_CR58","doi-asserted-by":"publisher","first-page":"356","DOI":"10.15386\/cjmed-760","volume":"90","author":"G POPA","year":"2017","unstructured":"POPA G, BLAG CL, BOTA M, ZOLOG A (2017) A malignant pheochromocytoma in a child with von Hippel-Lindau mutation. Clujul Med 90:356\u2013358. https:\/\/doi.org\/10.15386\/cjmed-760","journal-title":"Clujul Med"},{"key":"2571_CR59","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1515\/jpem-2012-0255","volume":"26","author":"Z Amini","year":"2013","unstructured":"Amini Z, Babovic-Vuksanovic D, Lteif A (2013) Bilateral pheochromocytomas in a child who had hemihypertrophy and alteration in the VHL gene. J Pediatr Endocrinol Metab JPEM 26:369\u2013372. https:\/\/doi.org\/10.1515\/jpem-2012-0255","journal-title":"J Pediatr Endocrinol Metab JPEM"},{"key":"2571_CR60","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.galenos.2024.2024-2-1","author":"K Pasternak-Pietrzak","year":"2024","unstructured":"Pasternak-Pietrzak K, Koz\u0142owska A, Moszczy\u0144ska E (2024) Hereditary pheochromocytoma as a main manifestation of von Hippel Lindau disease (vHL) in Childhood - A Long-term Follow-up of 5 patients with vHL from one family. J Clin Res Pediatr Endocrinol. https:\/\/doi.org\/10.4274\/jcrpe.galenos.2024.2024-2-1","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"2571_CR61","doi-asserted-by":"publisher","first-page":"luae160","DOI":"10.1210\/jcemcr\/luae160","volume":"2","author":"K Magnan","year":"2024","unstructured":"Magnan K, Wang Q, Meade J (2024) Multiple primary paragangliomas in a pediatric patient with von Hippel Lindau: A diagnostic dilemma. JCEM Case Rep 2:luae160. https:\/\/doi.org\/10.1210\/jcemcr\/luae160","journal-title":"JCEM Case Rep"},{"key":"2571_CR62","doi-asserted-by":"publisher","first-page":"e245154","DOI":"10.1136\/bcr-2021-245154","volume":"14","author":"BW-L Ng","year":"2021","unstructured":"Ng BW-L, Wong JS-L, Toh T-H (2021) Biochemically normal adrenal pheochromocytoma following extensive central necrosis in a child with von Hippel-Lindau (VHL) gene mutation. BMJ Case Rep 14:e245154. https:\/\/doi.org\/10.1136\/bcr-2021-245154","journal-title":"BMJ Case Rep"},{"key":"2571_CR63","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10689-021-00252-2","volume":"21","author":"I Fugaru","year":"2022","unstructured":"Fugaru I, Goudie C, Capolicchio J-P (2022) Von Hippel-Lindau disease and rapidly progressing pheochromocytomas in siblings. Fam Cancer 21:229\u2013233. https:\/\/doi.org\/10.1007\/s10689-021-00252-2","journal-title":"Fam Cancer"},{"key":"2571_CR64","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.urology.2017.12.007","volume":"119","author":"A Colvin","year":"2018","unstructured":"Colvin A, Saltzman AF, Walker J et al (2018) Metastatic pheochromocytoma in an asymptomatic 12-Year-Old with von Hippel-Lindau disease. Urology 119:140\u2013142. https:\/\/doi.org\/10.1016\/j.urology.2017.12.007","journal-title":"Urology"},{"key":"2571_CR65","doi-asserted-by":"publisher","unstructured":"Okada N, Shioya A, Togi S et al A case of von Hippel-Lindau disease with recurrence of paraganglioma and no other associated symptoms: the importance of genetic testing and Establishing Follow-Up policies. Cureus 15:e50484. https:\/\/doi.org\/10.7759\/cureus.50484","DOI":"10.7759\/cureus.50484"},{"key":"2571_CR66","doi-asserted-by":"publisher","unstructured":"Ardicli B, User IR, Ciftci A\u00d6 et al (2021) Approach to pheochromocytoma and paraganglioma in children and adolescents: A retrospective clinical study from a tertiary care center. J Pediatr Urol 17. https:\/\/doi.org\/10.1016\/j.jpurol.2021.01.043.:400.e1-400.e7","DOI":"10.1016\/j.jpurol.2021.01.043"},{"key":"2571_CR67","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s00467-020-04883-y","volume":"36","author":"A Boussetta","year":"2021","unstructured":"Boussetta A, Jellouli M, Meddeb R et al (2021) A rare cause of hypertension in an 11-year-old Boy: answers. Pediatr Nephrol Berl Ger 36:2021\u20132024. https:\/\/doi.org\/10.1007\/s00467-020-04883-y","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"2571_CR68","doi-asserted-by":"publisher","first-page":"267","DOI":"10.21037\/tau.2020.02.14","volume":"9","author":"M Li","year":"2020","unstructured":"Li M, Wang C, Liu P et al (2020) Clinical and genetic features of pediatric PCCs\/PGLs patients: a single-center experience in China. Transl Androl Urol 9:267\u2013275. https:\/\/doi.org\/10.21037\/tau.2020.02.14","journal-title":"Transl Androl Urol"},{"key":"2571_CR69","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1530\/ERC-13-0308","volume":"21","author":"RC Kruizinga","year":"2014","unstructured":"Kruizinga RC, Sluiter WJ, de Vries EGE et al (2014) Calculating optimal surveillance for detection of von Hippel-Lindau-related manifestations. Endocr Relat Cancer 21:63\u201371. https:\/\/doi.org\/10.1530\/ERC-13-0308","journal-title":"Endocr Relat Cancer"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02571-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02571-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02571-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:12:24Z","timestamp":1757160744000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02571-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":69,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["2571"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02571-y","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The research was performed in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee of Seth GS Medical College and KEM Hospital, Mumbai (Reference number EC\/OA-106\/2024). As this was a retrospective study, obtaining informed consent from participants was not applicable and was waived by the Institutional Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}